의료용 대화형 AI 시장 규모, 점유율, 동향 분석 보고서 : 구성요소별, 기술별, 용도별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)
Conversational AI In Healthcare Market Size, Share & Trends Analysis Report By Component (Chatbots, Virtual Assistants), By Technology (Speech Recognition & Generation), By Application, By End Use, By Region, And Segment Forecasts, 2025 - 2033
상품코드:1842190
리서치사:Grand View Research
발행일:2025년 09월
페이지 정보:영문 100 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
의료용 대화형 AI : 시장 개요
세계의 의료용 대화형 AI 시장 규모는 2024년에 136억 8,000만 달러로 평가되었으며, 2025년부터 2033년까지 25.71%의 CAGR로 성장하여 2033년에는 1,066억 7,000만 달러에 달할 것으로 예측됩니다. 환자 참여 개선에 대한 수요 증가, 원격의료와 원격 케어 채용 증가, 자연어 처리(NLP)와 AI 기술의 진보는, 시장 성장에 기여하는 중요한 요인입니다.
또한, 비용 효율성과 운영 최적화, 관리형 의료 워크플로우의 자동화는 시장 성장을 더욱 촉진하는 또 다른 요인입니다. 원격의료의 급속한 확산으로 가상 환자와의 상호작용과 진료 조정을 지원하는 대화형 AI의 필요성이 높아지고 있습니다. AI가 탑재된 챗봇은 원격진료 중 증상 선별, 후속 조치, 건강 교육을 가능하게 합니다. 대화형 AI는 환자와 임상의에게 실시간 지원을 제공함으로써 원격의료 플랫폼을 강화합니다. 원격 환자 모니터링 기기와 AI 기반 커뮤니케이션 도구를 결합하여 만성질환 관리와 순응도를 향상시킬 수 있습니다. AI 시스템의 편리성과 확장성은 전 세계적으로 원격의료의 보급을 촉진할 것입니다.
의료 서비스 제공자는 대화형 AI를 활용하여 진료의 연속성을 유지하고, 물리적 환경 밖에서 병원 재입원을 줄일 수 있습니다. 재택의료와 분산형 의료에 대한 수요 증가는 AI를 활용한 가상 의료 솔루션에 힘을 실어줄 것입니다. 예를 들어, 2025년 4월, Life는 Equiva와 제휴하여 대화형 AI 건강 멘토인 Dave(암 치료 전문가)와 Fred(일반 건강 및 생활습관 코치)를 Equiva의 병원 내 및 재택 플랫폼에 통합했습니다. 이 AI 컴패니언은 건강 관련 질문에 대한 답변, 환자 진료 준비, 의료 문서 번역, 퇴원 안내, 환자 맞춤형 감정 및 행동 코칭 등을 통해 실시간 지원을 제공합니다.
또한, 음성 인식 AI 비서의 채택이 증가하고 있는 것도 시장 성장을 촉진하고 있습니다. 음성 인식 AI 어시스턴트는 임상의와 환자에게 핸즈프리로 실시간 지원을 제공함으로써 의료 워크플로우를 혁신적으로 변화시키고 있습니다. 이러한 AI 도구는 임상 노트 기록, 스케줄링, EHR 검색 등의 관리 업무를 효율화합니다. 음성 비서는 의료진의 부담을 덜어주어 환자 진료에 더 집중할 수 있도록 도와주며, 오류를 최소화하고 소통을 강화합니다. 예를 들어, 2025년 5월 SoundHound AI는 Allina Health와 제휴하여 환자 참여와 치료 접근을 간소화하기 위해 설계된 AI 에이전트 'Alli'를 발표했습니다. 사운드하운드의 아멜리아 대화형 AI 플랫폼이 탑재된 Alli는 전자의무기록과 통합하여 발신자를 즉시 식별하고, 예약 관리, 약품 보충 및 의료기관 검색을 지원합니다.
목차
제1장 분석 방법·범위
제2장 주요 요약
제3장 의료용 대화형 AI 시장 : 변수, 동향, 범위
시장 연관 전망
상부 시장 전망
관련/부수 시장 전망
시장 역학
시장 성장 촉진요인 분석
시장 성장 억제요인 분석
시장 기회 분석
시장 과제 분석
의료용 대화형 AI 시장 : 분석 툴
업계 분석 : Porter's Five Forces 분석
PESTEL 분석
제4장 의료용 대화형 AI 시장 : 구성요소별 추정·동향 분석
부문 대시보드
세계의 의료용 대화형 AI 시장 : 변동 분석, 구성요소별
세계의 의료용 대화형 AI 시장 규모와 동향 분석 : 구성요소별(2021-2033년)
챗봇
가상 비서
음성 인식 시스템
서비스
제5장 의료용 대화형 AI 시장 : 기술별 추정·동향 분석
부문 대시보드
세계의 의료용 대화형 AI 시장 : 변동 분석, 기술별
세계의 의료용 대화형 AI 시장 규모와 동향 분석 : 기술별(2021-2033년)
음성 인식·생성
자연어 처리(NLP), 자연어 이해(NLU)
머신러닝·딥러닝 모델
대규모 언어 모델(LLM)과 생성형 AI
다이얼로그 관리·오케스트레이션
기타
제6장 의료용 대화형 AI 시장 : 용도별 추정·동향 분석
부문 대시보드
세계의 의료용 대화형 AI 시장 : 변동 분석, 용도별
세계의 의료용 대화형 AI 시장 규모와 동향 분석 : 용도별(2021-2033년)
환자 참여·서포트
정신건강 서포트, 테라피 봇
의료 진단, 임상 의사결정 지원
원격 환자 모니터링
원격의료, 가상 진찰
관리·워크플로우 자동화
의약품·약제 정보 지원
의료 연수·교육
기타
제7장 의료용 대화형 AI 시장 : 최종 용도별 추정·동향 분석
부문 대시보드
세계의 의료용 대화형 AI 시장 : 변동 분석, 최종 용도별
세계의 의료용 대화형 AI 시장 규모와 동향 분석 : 최종 용도별(2021-2033년)
병원·클리닉
환자·개인
의료 지불자·보험회사
제약·생명과학 기업
기타
제8장 의료용 대화형 AI 시장 : 지역별 추정·동향 분석
시장 점유율 분석 : 지역별(2024년·2033년)
시장 대시보드 : 지역별
시장 규모 예측과 동향 분석(2021-2033년)
북미
미국
캐나다
멕시코
유럽
영국
독일
프랑스
이탈리아
스페인
노르웨이
스웨덴
덴마크
아시아태평양
일본
중국
인도
호주
한국
태국
라틴아메리카
브라질
아르헨티나
중동 및 아프리카
남아프리카공화국
사우디아라비아
아랍에미리트
쿠웨이트
제9장 경쟁 구도
기업/경쟁 분류
전략 매핑
기업 시장 상황 분석(2024년)
기업 개요/상장 기업
Rasa Technologies Inc.
Corti
Enlitic, Inc.
IBM
UST
Authenticx
LivePerson
Hyro
Notable
Oncora Medical
NVIDIA Corporation
Mediktor
Nuance(Microsoft)
Fireflies
Abridge Al, Inc.
Babylon Health
Agora
Google
KSM
영문 목차
영문목차
Conversational AI In Healthcare Market Overview
The global conversational AI in healthcare market size was estimated at USD 13.68 billion in 2024 and is projected to reach USD 106.67 billion by 2033, growing at a CAGR of 25.71% from 2025 to 2033. Rising demand for improved patient engagement, increasing adoption of telehealth and remote care, and advancements in natural language processing (NLP) and AI technologies are significant factors contributing to market growth.
In addition, cost efficiency & operational optimization, and automation of administrative healthcare workflows are some other factors fueling market growth further. The rapid adoption of telemedicine amplifies the need for conversational AI to support virtual patient interactions and care coordination. AI-powered chatbots enable symptom triage, follow-ups, and health education during remote consultations. Conversational AI enhances telehealth platforms by providing real-time assistance to patients and clinicians. Remote patient monitoring devices combined with AI-driven communication tools improve chronic disease management and adherence. The convenience and scalability of AI systems boost telehealth penetration globally.
Healthcare providers leverage conversational AI to maintain continuity of care and reduce hospital readmissions outside physical settings. Increasing demand for home-based and decentralized healthcare drives AI-enabled virtual care solutions. For instance, in April 2025, Belong. Life partnered with Equiva to integrate its conversational AI health mentors, Dave (cancer care expert) and Fred (general health and lifestyle coach), into Equiva's in-hospital and home-based platforms. These AI companions provide real-time support by answering health questions, preparing patients for doctor visits, translating medical documents, guiding hospital discharge, and offering tailored emotional and behavioral coaching.
Furthermore, increasing adoption of voice-enabled AI assistants propels market growth. Voice-enabled AI assistants have transformed healthcare workflows by offering hands-free, real-time support for clinicians and patients. These AI tools streamline administrative tasks such as clinical note transcription, scheduling, and EHR retrieval. Voice assistants reduce provider workload, allowing more focus on patient care while minimizing errors and enhancing communication. For instance, in May 2025, SoundHound AI partnered with Allina Health to launch "Alli," an AI agent designed to streamline patient engagement and access to care. Powered by SoundHound's Amelia conversational AI platform, Alli integrates with electronic medical records to identify callers instantly, manage appointments, and support medication refills and provider searches.
Global Conversational AI In Healthcare Market Report Segmentation
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global conversational AI in healthcare market report based on component, technology, application, end use, and region:
Component Outlook (Revenue, USD Million, 2021 - 2033)
Chatbots
Virtual Assistants
Speech Recognition Systems
Services
Technology Outlook (Revenue, USD Million, 2021 - 2033)
Speech Recognition & Generation
Natural Language Processing (NLP) & Understanding (NLU)
Machine Learning & Deep Learning Models
Large Language Models (LLMs) & Generative AI
Dialogue Management & Orchestration
Others
Application Outlook (Revenue, USD Million, 2021 - 2033)
Patient Engagement & Support
Mental Health Support & Therapy Bots
Medical Diagnosis & Clinical Decision Support
Remote Patient Monitoring
Telemedicine & Virtual Consultations
Administrative & Workflow Automation
Pharmaceutical & Drug Information Assistance
Medical Training & Education
Others
End Use Outlook (Revenue, USD Million, 2021 - 2033)
Hospitals & Clinics
Patients & Individuals
Healthcare Payers & Insurance Companies
Pharmaceutical & Life Sciences Companies
Others
Regional Outlook (Revenue, USD Million, 2021 - 2033)
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
China
Japan
India
South Korea
Australia
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Market Definitions
1.2.1. Component Segment
1.2.2. Technology Segment
1.2.3. Application Segment
1.2.4. End Use
1.3. Information analysis
1.3.1. Market formulation & data visualization
1.4. Data validation & publishing
1.5. Information Procurement
1.5.1. Primary Research
1.6. Information or Data Analysis
1.7. Market Formulation & Validation
1.8. Market Model
1.9. Total Market: CAGR Calculation
1.10. Objectives
1.10.1. Objective 1
1.10.2. Objective 2
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Snapshot
2.3. Competitive Insights Landscape
Chapter 3. Conversational AI in Healthcare Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook.
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increasing adoption of telehealth and remote care
3.2.1.2. Advancements in natural language processing (NLP) and AI technologies
3.2.1.3. Rising demand for improved patient engagement
3.2.2. Market restraint analysis
3.2.2.1. Data security and privacy concerns
3.2.2.2. Limited Clinical Validation and Acceptance
3.2.3. Market opportunity analysis
3.2.4. Market challenges analysis
3.3. Conversational AI in Healthcare Market Analysis Tools
3.3.1. Industry Analysis - Porter's
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
3.3.2.4. Environmental Landscape
3.3.2.5. Legal Landscape
3.3.2.6. Social Landscape
Chapter 4. Conversational AI in Healthcare Market: Component Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Conversational AI in Healthcare Market Component Movement Analysis
4.3. Global Conversational AI in Healthcare Market Size & Trend Analysis, by Component, 2021 to 2033 (USD Million)
4.4. Chatbots
4.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.5. Virtual Assistants
4.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.6. Speech Recognition Systems
4.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
4.7. Services
4.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 5. Conversational AI in Healthcare Market: Technology Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Conversational AI in Healthcare Market Technology Movement Analysis
5.3. Global Conversational AI in Healthcare Market Size & Trend Analysis, by Technology, 2021 to 2033 (USD Million)
5.4. Speech Recognition & Generation
5.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.5. Natural Language Processing (NLP) & Understanding (NLU)
5.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.6. Machine Learning & Deep Learning Models
5.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.7. Large Language Models (LLMs) & Generative AI
5.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.8. Dialogue Management & Orchestration
5.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
5.9. Others
5.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 6. Conversational AI in Healthcare Market: Application Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Conversational AI in Healthcare Market Application Movement Analysis
6.3. Global Conversational AI in Healthcare Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
6.4. Patient Engagement & Support
6.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.5. Mental Health Support & Therapy Bots
6.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.6. Medical Diagnosis & Clinical Decision Support
6.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.7. Remote Patient Monitoring
6.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.8. Telemedicine & Virtual Consultations
6.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.9. Administrative & Workflow Automation
6.9.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.10. Pharmaceutical & Drug Information Assistance
6.10.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.11. Medical Training & Education
6.11.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
6.12. Others
6.12.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 7. Conversational AI in Healthcare Market: End Use Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Global Conversational AI in Healthcare Market End Use Movement Analysis
7.3. Global Conversational AI in Healthcare Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
7.4. Hospitals & Clinics
7.4.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.5. Patients & Individuals
7.5.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.6. Healthcare Payers & Insurance Companies
7.6.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.7. Pharmaceutical & Life Sciences Companies
7.7.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
7.8. Others
7.8.1. Market estimates and forecasts, 2021 to 2033 (USD Million)
Chapter 8. Conversational AI in Healthcare Market: Regional Estimates & Trend Analysis
8.1. Regional Market Share Analysis, 2024 & 2033
8.2. Regional Market Dashboard
8.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
8.4. North America
8.4.1. U.S.
8.4.1.1. Key country dynamics
8.4.1.2. Regulatory framework
8.4.1.3. Competitive scenario
8.4.1.4. U.S. market estimates and forecasts, 2021 to 2033 (USD Million)
8.4.2. Canada
8.4.2.1. Key country dynamics
8.4.2.2. Regulatory framework
8.4.2.3. Competitive scenario
8.4.2.4. Canada market estimates and forecasts, 2021 to 2033 (USD Million)
8.4.3. Mexico
8.4.3.1. Key country dynamics
8.4.3.2. Regulatory framework
8.4.3.3. Competitive scenario
8.4.3.4. Mexico market estimates and forecasts, 2021 to 2033 (USD Million)
8.5. Europe
8.5.1. UK
8.5.1.1. Key country dynamics
8.5.1.2. Regulatory framework
8.5.1.3. Competitive scenario
8.5.1.4. UK market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.2. Germany
8.5.2.1. Key country dynamics
8.5.2.2. Regulatory framework
8.5.2.3. Competitive scenario
8.5.2.4. Germany market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.3. France
8.5.3.1. Key country dynamics
8.5.3.2. Regulatory framework
8.5.3.3. Competitive scenario
8.5.3.4. France market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.4. Italy
8.5.4.1. Key country dynamics
8.5.4.2. Regulatory framework
8.5.4.3. Competitive scenario
8.5.4.4. Italy market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.5. Spain
8.5.5.1. Key country dynamics
8.5.5.2. Regulatory framework
8.5.5.3. Competitive scenario
8.5.5.4. Spain market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.6. Norway
8.5.6.1. Key country dynamics
8.5.6.2. Regulatory framework
8.5.6.3. Competitive scenario
8.5.6.4. Norway market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.7. Sweden
8.5.7.1. Key country dynamics
8.5.7.2. Regulatory framework
8.5.7.3. Competitive scenario
8.5.7.4. Sweden market estimates and forecasts, 2021 to 2033 (USD Million)
8.5.8. Denmark
8.5.8.1. Key country dynamics
8.5.8.2. Regulatory framework
8.5.8.3. Competitive scenario
8.5.8.4. Denmark market estimates and forecasts, 2021 to 2033 (USD Million)
8.6. Asia Pacific
8.6.1. Japan
8.6.1.1. Key country dynamics
8.6.1.2. Regulatory framework
8.6.1.3. Competitive scenario
8.6.1.4. Japan market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.2. China
8.6.2.1. Key country dynamics
8.6.2.2. Regulatory framework
8.6.2.3. Competitive scenario
8.6.2.4. China market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.3. India
8.6.3.1. Key country dynamics
8.6.3.2. Regulatory framework
8.6.3.3. Competitive scenario
8.6.3.4. India market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.4. Australia
8.6.4.1. Key country dynamics
8.6.4.2. Regulatory framework
8.6.4.3. Competitive scenario
8.6.4.4. Australia market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.5. South Korea
8.6.5.1. Key country dynamics
8.6.5.2. Regulatory framework
8.6.5.3. Competitive scenario
8.6.5.4. South Korea market estimates and forecasts, 2021 to 2033 (USD Million)
8.6.6. Thailand
8.6.6.1. Key country dynamics
8.6.6.2. Regulatory framework
8.6.6.3. Competitive scenario
8.6.6.4. Thailand market estimates and forecasts, 2021 to 2033 (USD Million)
8.7. Latin America
8.7.1. Brazil
8.7.1.1. Key country dynamics
8.7.1.2. Regulatory framework
8.7.1.3. Competitive scenario
8.7.1.4. Brazil market estimates and forecasts, 2021 to 2033 (USD Million)
8.7.2. Argentina
8.7.2.1. Key country dynamics
8.7.2.2. Regulatory framework
8.7.2.3. Competitive scenario
8.7.2.4. Argentina market estimates and forecasts, 2021 to 2033 (USD Million)
8.8. MEA
8.8.1. South Africa
8.8.1.1. Key country dynamics
8.8.1.2. Regulatory framework
8.8.1.3. Competitive scenario
8.8.1.4. South Africa market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.2. Saudi Arabia
8.8.2.1. Key country dynamics
8.8.2.2. Regulatory framework
8.8.2.3. Competitive scenario
8.8.2.4. Saudi Arabia market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.3. UAE
8.8.3.1. Key country dynamics
8.8.3.2. Regulatory framework
8.8.3.3. Competitive scenario
8.8.3.4. UAE market estimates and forecasts, 2021 to 2033 (USD Million)
8.8.4. Kuwait
8.8.4.1. Key country dynamics
8.8.4.2. Regulatory framework
8.8.4.3. Competitive scenario
8.8.4.4. Kuwait market estimates and forecasts, 2021 to 2033 (USD Million)
